Key result
Combined administration of anti-inflammatory and antithrombotic therapy may increase the effectiveness of post-pericardiotomy syndrome treatment, though the optimal combination remains to be determined.
Why the study?
Choosing the optimal combination of agents affecting both inflammation and thrombosis risk is an important problem in managing post-pericardiotomy syndrome.
Answers are grounded in this paper and cite their sources.
Combined anti-inflammatory and antithrombotic therapy may be important for managing post-pericardiotomy syndrome, given the interplay between inflammation and hemostasis.
Post-pericardiotomy syndrome (PPS) follows open cardiac surgery. This inflammatory process is accompanied by symptoms of pericarditis and/or pleuritis. Anti-inflammatory drugs are the main therapy in these patients. The theory of correlation between inflammation and clotting becomes widespread. Effectiveness of their complex treatment for infectious (new coronavirus infection) and non-infectious (coronary artery disease) diseases is being actively studied. Inflammation, previous surgery, cardiopulmonary bypass, and features of postoperative management can affect hemostasis system in patients with PPS. In addition, various medications for treatment of inflammation reduce or increase the risk of thrombosis. Combined administration of anti-inflammatory and antithrombotic therapy should increase the effectiveness of PPS treatment. Such therapy is really carried out, since the majority of cardiac surgical patients receive antiplatelet agents and/or anticoagulants in postoperative period to treat the underlying disease and prevent its complications. The problem of choosing the optimal combination of agents affecting inflammation and risk of thrombosis is very important.
No takes yet. Share an insight, caveat, or question.
Mangileva et al. (2023) conducted a review in Post-pericardiotomy syndrome. Combined anti-inflammatory and antithrombotic therapy was evaluated. Combined administration of anti-inflammatory and antithrombotic therapy may increase the effectiveness of post-pericardiotomy syndrome treatment, though the optimal combination remains to be determined.
Synapse has enriched 10 related papers. Consider them for comparative context: